title: Fate of novel painkiller mAbs hangs in balance.
authors.forename: Ken
authors.initials: K
authors.lastname: Garber
mesh_terms: D000700:Analgesics / Q000009:adverse effects / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D017277:Drug Approval; D006801:Humans; D010146:Pain / Q000517:prevention & control*; D020800:Receptor, Nerve Growth Factor / Q000037:antagonists & inhibitors*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000700:Analgesics; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D020800:Receptor, Nerve Growth Factor; C549319:tanezumab